Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
12,101,980
-
Share change
-
-41,544
-
Total reported value
-
$504,803,422
-
Price per share
-
$41.74
-
Number of holders
-
149
-
Value change
-
-$2,417,194
-
Number of buys
-
73
-
Number of sells
-
69
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q1 2021
As of 31 Mar 2021,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
149 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,101,980 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, VANGUARD GROUP INC, BRANDES INVESTMENT PARTNERS, LP, Park West Asset Management LLC, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., Smith, Graham & Co., Investment Advisors, LP, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
149
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.